A Study to Assess the Safety and Effectiveness of Palivizumab Administered to Children at High Risk of Severe Respiratory Syncytial Virus (RSV) Infection in the Russian Federation and the Republic of Belarus
Clinical trial NCT02968173 · COMPLETED
Trial details
- NCT number
- NCT02968173
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-09
- Primary completion
- 2017-07-13
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.